L-Carnitine Treatment of Adult Rats With Busulfan-Induced Oligospermia
Abstract
Abstract. The purpose of this research was to examine the effects of L-carnitine treatment on adult rats that had busulfan-induced oligospermia. In our experiment, we used twenty-one adult male rats, each weighing around 200 g. Three groups of rats were used for the experiments: The first set of subjects, called the control group, had DMSO administered intraperitoneally and 1 mL of pure water gavaged orally once daily. The second group received 20 mg/kg of busulfan (Bus) administered IP once daily along with a daily oral gavage of 1 ml of distilled water. The third set of subjects received a single I.P. of busulfan along with L-carnitine (L-car) and busulfan administered orally. One day after busulfan injection, L-carnitine were administered for a duration of 28 days at 350 mg/kg.bw. After dissecting, the epididymis and testis were meticulously removed and weighed, along with any excess fat and blood. The spermatozoa were taken from the removed caudal epididymis and incubated in PBS medium containing at 37C for 5 minutes, this used for counting and checking abnormalities. MDA and GSH were also estimated in testes tissues by using HPLC. The administration of BU resulted in a substantially testes weight, and relative testes weight (p <.05) as compared to the control group. testes weight, and relative testes weight were all markedly improved with L-carnitine administration as compared to G2. after administering BU, sperm count and motility were significantly lower (p <.05) compared to G1. There was a significant improvement in motility, sperm count, and abnormalities with L-carnitine administration compared to G2. after BU was administered, MDA were considerably higher and GSH significantly lower (p <.05) as compared to G1. The results of measuring oxidative stress indicators were dramatically improved with L-carnitine administration when contrasted with G2. In conclusion, Busulfan may have a negative impact on male fertility if taken alone, but when combined with L-carnitine, the drug's cytotoxic effects can be mitigated, protecting both testis and semen.
Highlights:
- L-carnitine Treatment: Significantly improved testis weight and sperm quality in busulfan-treated rats.
- Oxidative Stress Reduction: L-carnitine mitigated increased MDA levels and restored GSH in testicular tissue.
- Fertility Protection: Co-administration of L-carnitine reduced the cytotoxic effects of busulfan on male fertility.
Keywords: L-carnitine, busulfan, oligospermia, male fertility, oxidative stress
References
T. Iwamoto, Y. Hiraku, S. Oikawa, H. Mizutani, M. Kojima, and S. Kawanishi, “DNA intrastrand cross-link at the 5′-GA-3′ sequence formed by busulfan and its role in the cytotoxic effect,” Cancer Science, vol. 95, no. 5, pp. 454–458, 2004. doi: 10.1111/j.1349-7006.2004.tb03231.x.
M. Houot, V. Poinsignon, L. Mercier, C. Valade, R. Desmaris, F. Lemare, and A. Paci, “Physico-chemical stability of busulfan in injectable solutions in various administration packages,” Drugs in R&D, vol. 13, no. 1, pp. 87–94, 2013. doi: 10.1007/s40268-013-0003-y.
S.-W. Jung, H.-J. Kim, B.-H. Lee, S.-H. Choi, H.-S. Kim, Y.-K. Choi, and S.-Y. Nah, “Effects of Korean Red Ginseng extract on busulfan-induced dysfunction of the male reproductive system,” Journal of Ginseng Research, vol. 39, no. 3, pp. 243–249, 2015. doi: 10.1016/j.jgr.2015.01.002.
F. Dehghani, A. Hassanpour, A. Poost-Pasand, A. Noorafshan, and S. Karbalay-Doust, “Protective effects of L-carnitine and homogenized testis tissue on the testis and sperm parameters of busulfan-induced infertile male rats,” Iranian Journal of Reproductive Medicine, vol. 11, no. 9, pp. 693–704, 2013. [Online]. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3941323&tool=pmcentrez&rendertype=abstract.
S. D. H. Ahmed, K. A. Karira, J. Jagdesh, and S. Ahsan, “Role of L-carnitine in male infertility,” Journal of the Pakistan Medical Association, vol. 61, no. 8, pp. 732–736, 2011.
M. N. Chiu, M. R. Blackman, C. Wang, and R. S. Swerdloff, “The role of carnitine in the male reproductive system,” Annals of the New York Academy of Sciences, vol. 1033, pp. 177–188, 2004. doi: 10.1196/annals.1320.017.
A. Agarwal and T. M. Said, “Carnitines and male infertility,” Reproductive Biomedicine Online, vol. 8, no. 4, pp. 376–384, 2004.
J. L. Miguel-Carrasco, A. Mate, M. T. Monserrat, J. L. Arias, O. Aramburu, and C. M. Vázquez, “The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension,” American Journal of Hypertension, vol. 21, no. 11, pp. 1231–1237, 2008. doi: 10.1038/ajh.2008.271.
B. Buzadzic, M. Vucetic, A. Jankovic, A. Stancic, A. Korac, B. Korac, and V. Otasevic, “New insights into male (in)fertility: The importance of NO,” British Journal of Pharmacology, vol. 172, no. 6, pp. 1455–1467, 2015. doi: 10.1111/bph.12675.
A. F. Khosoroshahi et al., “An investigation into the effect of exogenous melatonin on spermatogenesis of pinealectomised busulfan-induced oligospermic adult rats, 2008-2009,” Journal of Kermanshah University of Medical Sciences, vol. 16, no. 6, pp. 435–444, 2012.
S. Ghanbarzadeh, A. Garjani, M. Ziaee, and A. Khorrami, “Effects of L-carnitine and coenzyme Q10 on impaired spermatogenesis caused by isoproterenol in male rats,” Drug Research, vol. 64, no. 9, pp. 449–453, 2013. doi: 10.1055/s-0033-1361103.
S. K. Padmanabhaiah, “Effect of ribavirin on epididymal sperm count in rat,” 2016.
R. P. Amann and D. Waberski, “Computer-assisted sperm analysis (CASA): Capabilities and potential developments,” Theriogenology, vol. 81, no. 1, pp. 5–17, 2014. doi: 10.1016/j.theriogenology.2013.09.004.
M. Monsefi, B. Fereydouni, L. Rohani, and T. Talaei, “Mesenchymal stem cells repair germinal cells of seminiferous tubules of sterile rats,” Iranian Journal of Reproductive Medicine, vol. 11, no. 7, pp. 537–544, 2013. [Online]. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3941348&tool=pmcentrez&rendertype=abstract.
M. Mirhoseini, G. Saki, M. Hemadi, A. Khodadadi, and J. Mohammadi Asl, “Melatonin and testicular damage in busulfan treated mice,” Iranian Red Crescent Medical Journal, vol. 16, no. 2, e14463, 2014. doi: 10.5812/ircmj.14463.
T. Ohira, T. Saito, R. Ando, K. Tamura, and T. Hoshiya, “Systemic histopathology of infant rats exposed to busulfan,” Journal of Toxicologic Pathology, vol. 27, no. 1, pp. 25–29, 2014. doi: 10.1293/tox.2013-0043.
N. H. Ahar, A. Khaki, G. Akbari, and M. Ghafarinovin, “The effect of busulfan on body weight, testis weight and MDA enzymes in male rats,” International Journal of Women’s Health and Reproduction Sciences, vol. 2, no. 5, pp. 316–319, 2014. doi: 10.15296/ijwhr.2014.52.
Z. Hassan, M. Hassan, and E. Hellstrom-Lindberg, “The pharmacodynamic effect of busulfan in the P39 myeloid cell line in vitro,” Leukemia, vol. 15, no. 8, pp. 1240–1247, 2001. doi: 10.1038/sj.leu.2402193.
S. Eskiocak et al., “Effect of psychological stress on the L-arginine-nitric oxide pathway and semen quality,” Brazilian Journal of Medical and Biological Research, vol. 39, no. 5, pp. 581–588, 2006. doi: 10.1590/s0100-879x2006000500003.
E. Vicari and A. E. Calogero, “Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis,” Human Reproduction, vol. 16, no. 11, pp. 2338–2342, 2001.
O. Abdel-Hamed, A. I. El-Sayed, M. M. Iraqi, A. M. Saad, and A. A. Radwan, “Comparative evaluation of different herbal formula and L-Carnitine on reproductive performance of male Moshtohor rabbits,” in 2nd International Conference on Biotechnology Applications in Agriculture (ICBAA), April 2014, pp. 8–12.
F. Mazzilli, T. Rossi, C. Ronconi, B. Germini, and F. Dondero, “[Intra-spermatic L-carnitine and survival of sperm motility],” Minerva Ginecologica, vol. 51, no. 4, pp. 129–134, 1999.
A. Lenzi et al., “A placebo-controlled double-blind randomized trial of the use of combined L-carnitine and L-acetyl-carnitine treatment in men with asthenozoospermia,” Fertility & Sterility, vol. 81, no. 6, pp. 1578–1584, 2004.
E. Aliabad et al., “Effects of L-carnitine and L-acetyl-carnitine on testicular sperm motility and chromatin quality,” Iranian Journal of Reproductive Medicine, vol. 10, no. 2, pp. 77–82, 2012. PMCID: PMC4163266.